VectorY combines the therapeutic potential of antibodies and gene therapy to develop long-lasting therapeutic solutions for large disease areas of high unmet medical need. By combining state-of-the-art technologies and novel and scientific concepts, VectorY’s mission is to bring innovative therapies to patients worldwide.

Biotechnology

VectorY

Sander Van Deventer

Michael Wyzga

Wouter Pos

Claus Sundgreen

Sandra Lemmens

Rob Haselberg

Raygene Martier, PhD

Marco Boorsma

Femke Hoeksema

Elena Ritsou

Barbara Sanders

André Verwei

Pavlina Konstantinova

The Scientific and Technical Team at VectorY focuses on the research and development of innovative gene and antibody therapies. This multidisciplinary team collaborates to advance vector development, optimize gene therapy techniques, enhance assay methods, and scale up processes. Their collective expertise drives the creation and implementation of cutting-edge therapeutic solutions to address high unmet medical needs globally.

Scientific and Technical Team

Advisory and Board Members

Leadership Team

Scientific and Technical Team

About

Team members

Other teams at VectorY

Advisory and Board Members

Leadership Team